chronic kidney disease
Conditions
Interventions
Roxadustat:no intervention
Erythropoietin:no intervention
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years; 2. Regular peritoneal dialysis for at least 6 weeks; 3. Within 6 weeks, the patient did not receive erythropoietin, roxadustat or iron supplementation. 4. Mean HB70-100g /L (mean of two most recent Hb measurements taken at least one week apart during screening and prior to enrollment, absolute difference <= 10g/L between the two measurements).
Exclusion criteria
Exclusion criteria: 1. Change the dialysis method or combine with other dialysis methods; 2. Serious organic dysfunction of heart, liver, lung and brain; 3. Pregnant and lactation women; 4. Incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hepcidin;serum transferrin receptor;ferritin;iron transporter saturation; | — |
Secondary
| Measure | Time frame |
|---|---|
| total iron binding capacity;unsaturated iron-binding capacity;Hemoglobin;reticulocyte count;Erythropoietin;serum creatinine;estimated glomerular filtration rate;serum potassium;total cholesterol;Triglyceride;high-density lipoprotein;Low density lipoprotein; | — |
Countries
China
Contacts
Public ContactSun Dong
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed